Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100QFOG
Period2022-01-01 → 2022-12-31
Filed2023-03-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed

Amended by S100QG6E (2023-03-24).

Key figures · 100
MetricValuePeriodScopeSource row
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31Cons.Net assets
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees122at 2022-12-31Cons.Number of employees
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.8bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥1.0bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥2.8bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31StandaloneAssets
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.2bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Total liabilities¥1.7bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥3.9bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥4.8bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-165.542018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥212.23at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.1%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued83,398,924at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31StandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees
Employees90at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2022-12-31122 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,061
ItemContextValueUnit
Cash and cash equivalents (5-year summary)Prior1YearInstant－JPY
Cash and cash equivalents (5-year summary)CurrentYearInstant6282554000JPY
Number of employeesPrior4YearInstant－
Number of employeesPrior3YearInstant－
Number of employeesPrior2YearInstant－
Number of employeesPrior1YearInstant－
Number of employeesCurrentYearInstant122
Average number of temporary workersPrior4YearInstant－
Average number of temporary workersPrior3YearInstant－
Average number of temporary workersPrior2YearInstant－
Average number of temporary workersPrior1YearInstant－
Average number of temporary workersCurrentYearInstant30
Net sales (5-year summary)Prior4YearDuration_NonConsolidatedMember3835530000JPY
Net sales (5-year summary)Prior3YearDuration_NonConsolidatedMember2837753000JPY
Net sales (5-year summary)Prior2YearDuration_NonConsolidatedMember2987051000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember8256924000JPY
Net sales (5-year summary)CurrentYearDuration_NonConsolidatedMember10008338000JPY
Ordinary income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-2748730000JPY
Ordinary income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-4376655000JPY
Ordinary income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-4615903000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember1001133000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember2001204000JPY
Net income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-2752533000JPY
Net income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-4376258000JPY
Net income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-4090216000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember2032203000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember1186022000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior4YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior3YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior2YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior4YearInstant_NonConsolidatedMember12972579000JPY
Capital stock (5-year summary)Prior3YearInstant_NonConsolidatedMember14870639000JPY
Capital stock (5-year summary)Prior2YearInstant_NonConsolidatedMember17044943000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember17157628000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember17548459000JPY
Total number of issued shares (5-year summary)Prior4YearInstant_NonConsolidatedMember83398924
Total number of issued shares (5-year summary)Prior3YearInstant_NonConsolidatedMember26437681
Total number of issued shares (5-year summary)Prior2YearInstant_NonConsolidatedMember38202956
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember38457206
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember39603606
Net assets (5-year summary)Prior4YearInstant_NonConsolidatedMember4901799000JPY
Net assets (5-year summary)Prior3YearInstant_NonConsolidatedMember4400116000JPY
Net assets (5-year summary)Prior2YearInstant_NonConsolidatedMember4657318000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember6745672000JPY
Net assets (5-year summary)CurrentYearInstant_NonConsolidatedMember8511025000JPY
Total assets (5-year summary)Prior4YearInstant_NonConsolidatedMember6239423000JPY
Total assets (5-year summary)Prior3YearInstant_NonConsolidatedMember5273955000JPY
Total assets (5-year summary)Prior2YearInstant_NonConsolidatedMember6274707000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass